92 related articles for article (PubMed ID: 1564545)
1. Suppression of anchorage-independent growth of human glioblastoma cell by major histocompatibility complex class I gene-transfection.
Momozaki N; Oh-Uchida M; Tabuchi K; Ikezaki K; Hori K
J Neurosurg; 1992 May; 76(5):845-9. PubMed ID: 1564545
[TBL] [Abstract][Full Text] [Related]
2. Xenogenization of a mouse lung carcinoma (3LL) by transfection with an allogeneic class I major histocompatibility complex gene (H-2Ld).
Itaya T; Yamagiwa S; Okada F; Oikawa T; Kuzumaki N; Takeichi N; Hosokawa M; Kobayashi H
Cancer Res; 1987 Jun; 47(12):3136-40. PubMed ID: 3107804
[TBL] [Abstract][Full Text] [Related]
3. Partial suppression of anchorage-independent growth and tumorigenicity in immunodeficient mice by transfection of the H-2 class I gene H-2Ld into a human colon cancer cell line (HCT).
Gattoni-Celli S; Willett CG; Rhoads DB; Simon B; Strauss RM; Kirsch K; Isselbacher KJ
Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8543-7. PubMed ID: 3186742
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
Li M; Muller J; Xu F; Hearing VJ; Gorelik E
Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142
[TBL] [Abstract][Full Text] [Related]
5. Altered growth of a human neuroendocrine carcinoma line after transfection of a major histocompatibility complex class I gene.
Sunday ME; Isselbacher KJ; Gattoni-Celli S; Willett CG
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4700-4. PubMed ID: 2660144
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of MHC class I antigen in insulinoma cells controlled by the R1 element of the H-2 enhancer.
Ye X; Kralli A; Ge R; Ricciardi RP; Knowles BB
Oncogene; 1994 Apr; 9(4):1195-204. PubMed ID: 8134122
[TBL] [Abstract][Full Text] [Related]
7. Analysis of hybrid H-2D and L antigens with reciprocally mismatched aminoterminal domains: functional T cell recognition requires preservation of fine structural determinants.
McCluskey J; Boyd L; Foo M; Forman J; Margulies DH; Bluestone JA
J Immunol; 1986 Dec; 137(12):3881-90. PubMed ID: 2431046
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of induction of class I major histocompatibility antigen expression by murine leukemia virus.
Faller DV; Wilson LD; Flyer DC
J Cell Biochem; 1988 Mar; 36(3):297-309. PubMed ID: 3288646
[TBL] [Abstract][Full Text] [Related]
9. Human glioma immunobiology in vitro: implications for immunogene therapy.
Parney IF; Farr-Jones MA; Chang LJ; Petruk KC
Neurosurgery; 2000 May; 46(5):1169-77; discussion 1177-8. PubMed ID: 10807250
[TBL] [Abstract][Full Text] [Related]
10. Major histocompatibility gene therapy: the importance of haplotype and beta 2-microglobulin.
Salamone FN; Gleich LL; Li YQ; Stambrook PJ
Laryngoscope; 2004 Apr; 114(4):612-5. PubMed ID: 15064612
[TBL] [Abstract][Full Text] [Related]
11. Endocytosis of the class I major histocompatibility antigen via a phorbol myristate acetate-inducible pathway is a cell-specific phenomenon and requires the cytoplasmic domain.
Capps GG; Van Kampen M; Ward CL; Zúñiga MC
J Cell Biol; 1989 Apr; 108(4):1317-29. PubMed ID: 2925787
[TBL] [Abstract][Full Text] [Related]
12. Induction and maintenance of T-cell response to a nonimmunogenic murine mesothelioma cell line requires expression of B7-1 and the capacity to upregulate class II major histocompatibility complex expression.
Leong C; Marley J; Loh S; Robinson B; Garlepp M
Cancer Gene Ther; 1996; 3(5):321-30. PubMed ID: 8894251
[TBL] [Abstract][Full Text] [Related]
13. Role of histocompatibility antigen gene and protooncogene expressions in intracerebral tumorigenicity of mouse neuroblastoma.
Yamasaki T; Klein G; Ljunggren HG; Kärre K; Moritake K; Paine JT; Kikuchi H
J Neurosurg; 1993 Apr; 78(4):619-29. PubMed ID: 8450336
[TBL] [Abstract][Full Text] [Related]
14. Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.
Ly A; Duc HT; Kalamarides M; Trojan LA; Pan Y; Shevelev A; François JC; Noël T; Kane A; Henin D; Anthony DD; Trojan J
Mol Pathol; 2001 Aug; 54(4):230-9. PubMed ID: 11477137
[TBL] [Abstract][Full Text] [Related]
15. Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2.
Crumpacker DB; Alexander J; Cresswell P; Engelhard VH
J Immunol; 1992 May; 148(10):3004-11. PubMed ID: 1374446
[TBL] [Abstract][Full Text] [Related]
16. Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme.
Yang I; Kremen TJ; Giovannone AJ; Paik E; Odesa SK; Prins RM; Liau LM
J Neurosurg; 2004 Feb; 100(2):310-9. PubMed ID: 15086239
[TBL] [Abstract][Full Text] [Related]
17. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
Karlhofer FM; Ribaudo RK; Yokoyama WM
Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
[TBL] [Abstract][Full Text] [Related]
18. Some cloned murine CD4+ T cells recognize H-2Ld class I MHC determinants directly. Other cloned CD4+ T cells recognize H-2Ld class I MHC determinants in the context of class II MHC molecules.
McKisic MD; Sant AJ; Fitch FW
J Immunol; 1991 Nov; 147(9):2868-74. PubMed ID: 1717578
[TBL] [Abstract][Full Text] [Related]
19. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
20. Influence on metastasis of the reduction of major histocompatibility complex (MHC) class I gene with an antisense oligonucleotide.
Kanbe M; Arita D; Satoh T; Yokoyama A; Murakawa Y; Kikuchi H; Kanamaru R
Anticancer Drug Des; 1992 Aug; 7(4):341-50. PubMed ID: 1510801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
